Junshi Creatures

Domestic new crown drugs will be tough with Pfizer head-on, and the first 28 days will be known at the earliest
Covid Pfizer paxlovid vv116 China Clinical Trials Registry Junshi Creatures
04-22
The first domestic new crown oral drug is coming? The latest release from this company: Significantly reduce the risk of critical illness and death!
take orally Pruk Covid vv116 Junshi Creatures Azfedine
04-18
The first domestic new crown oral drug is coming? The latest release from this company
take orally Covid Pruk vv116 Azfedine Junshi Creatures
04-18
It can effectively reduce the mortality rate of new crown patients! Pioneering pharmaceutical stock price doubled, chairman: promote the application for emergency medication
Pioneering the pharmaceutical industry Pkrutamide Covid Junshi Creatures
04-06
Myth shattered, Junshi PD-1 sales fell by 60%, soul bargaining does not back the pot
pd-1 Junshi Tripril monoclonal antibody Junshi Creatures AstraZeneca
04-01
Nine drugs were approved for marketing this week, and three were used for immune diseases
Immune diseases Rheumatoid arthritis Solution for injection hepatitis B Junshi Creatures
03-05
Well-known pharmaceutical companies have stopped production related to the epidemic; a large number of self-made Chinese medicines have entered the provincial medical insurance; and the lottery income will be invested in the pension
Health care Coronavirus Production Public medical institutions Medical institutions Junshi Creatures
02-27
The progress of the research and development of a number of domestic new crown oral drugs has been announced, which ones are expected to apply for listing within the year?
take orally Covid drugs Ritonavir Goree Pharma Junshi Creatures Wangshan 李宁 Pkrutamide Pioneering the pharmaceutical industry
02-15
On the COVID-19 oral drug track, there are these companies racing...
Coronavirus take orally clinical trial Junshi Creatures vv116 Huachuang Securities Gilead Sun Jiehua sheet Zhang Xiaoguang
02-08
Junshi Biological new crown drugs have a new action, CEO Li Ning: Domestic to see oral drugs
Junshi Creatures drugs take orally Covid
01-28
The effect of combination immunotherapy for nasopharyngeal carcinoma is "amazing", and tripramide is included in the new version of the medical insurance directory
Tripril monoclonal antibody Nasopharyngeal carcinoma Metastatic nasopharyngeal carcinoma chemotherapy Junshi Creatures
01-26
Finding a new outlet, PD-1 hopes to rekindle?
3SBio Group Sansheng Guojian AstraZeneca Junshi Creatures China Biopharma
01-06
【Medical Companion Travel】What is Junshi Bio CD39 Monoclonal Antibody Approved Clinical CD39?
cd39 Junshi Creatures tumor js019
12-31